Toyama K, Eto T, Takazawa K, Shimizu S, et al. DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study. Vaccine 2023 Aug 14:S0264-410X(23)00824-1. doi: 10.1016/j.vaccine.2023.
PMID: 37586958